All news from Anaesthesiology

Dupilumab Alleviates Asthma Symptoms, Study Finds

New studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable anti-inflammatory drug, was approved in 2017 by the Food and Drug Administration as a treatment for eczema, a chronic skin disease.

Role of NATHEALTH in the Making of a 'New Indian Health Economy'

On the occasion of 6th anniversary, Healthcare Federation of India (NATHEALTH) said that rising patient consumerism, expansion of the continuum of care, a shift towards quality based-care, increasing patient participation, the use of technology in delivering care, and increasing insurance penetration are some of the disruptive trends which India is presently witnessing.

Common Mental Illness Is Occured From Job Strain

According to a study, researchers examine that workplaces that reduce job strain could prevent up to 14% of new cases of common mental illness from occurring. They confirm that high job strain is associated with an increased risk of developing common mental disorders such as depression and anxiety amongst middle-aged workers. The study was published in the Lancet Psychiatry.

Trachoma Eliminated in Nepal

The Government of Nepal has eliminated trachoma as a public health problem, according to a recent announcement by the World Health Organization (WHO). With this announcement, Nepal joins a small number of countries in achieving validation of trachoma elimination.  Their success demonstrates clear progress in the global fight against NTDs for the remaining trachoma-endemic countries.

Use of Ebselen in MND Cure

An international study led by biochemists at the University of Liverpool has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease (MND).

Symptoms in Head and Neck Cancer Reduced by Remote Tracking

Patients with head and neck cancer who undergo radiation treatment have a high symptom burden and are at an increased risk for dehydration. When such patients were given a remote tracking system to record their symptoms, they subsequently recorded less severity in their symptoms than did a control group of patients who were followed with usual care.